Laboratory News and Research

RSS

Biologic drug can help treat contact dermatitis

APOSEC it is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna.

15 May 2020

EKF & Tosoh Europe N.V. distribution agreement expands HbA1c POC testing reach in Middle East & Africa

EKF Diagnostics, the global in vitro diagnostics company, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V. for the distribution of its Quo-Test HbA1c point-of-care analyzer in the Middle East and Africa.

From EKF Diagnostics 15 May 2020

Researchers investigate the troubling trend of heart injury in COVID-19 patients

Researchers are finding about half of all patients with COVID-19 admitted to an intensive care unit have heart damage.

15 May 2020

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.

15 May 2020

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

The UK’s leading supplier of human tissue samples is joining forces with a Cambridge Biobank to provide COVID-19 samples for scientists.

15 May 2020

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

Scientists produce corals with increased heat tolerance to reduce reef bleaching

A team of scientists has successfully produced in a laboratory setting a coral that is more resistant to increased seawater temperatures.

15 May 2020

BGU researcher develops one-minute COVID-19 breath test

Ben-Gurion University of the Negev's Prof. Gabby Sarusi has developed and is now validating a test that identifies carriers of the COVID-19 virus in less than a minute with greater than 90% accuracy and at a dramatically lower price than any other method available.

15 May 2020

CSHLP Press releases new book on heart development and disease

Cold Spring Harbor Laboratory Press (CSHLP) announced the release of Heart Development and Disease, available on its website in hardcover and eBook formats.

15 May 2020

TUM researchers develop innovative x-ray method for lung diagnostics

Researchers at the Technical University of Munich have developed an innovative x-ray method for lung diagnostics, which they now plan to test in one of its first applications for diagnosis of the respiratory ailment COVID-19 caused by Coronavirus.

15 May 2020

Army scientists apply new techniques to modify brain activity

For Army scientists, the goal of neuroscience research is pursuing the inner workings of the human brain to advance scientific understanding and improve Soldier performance.

14 May 2020

ACMG: Technical standard on CFTR variant testing updated

It has been nearly two decades since the American College of Medical Genetics and Genomics, together with the American College of Obstetricians and Gynecologists, made the landmark recommendation that cystic fibrosis (CF) become the first target of pan-ethnic universal carrier screening, with ACMG identifying a core panel of 23 pathogenic variants to be tested.

14 May 2020

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

Daniel Preston, an assistant professor of mechanical engineering at Rice's Brown School of Engineering, has received a National Science Foundation Rapid Response Research grant to study the effect of varying temperatures on the lifetime of the virus responsible for the COVID-19 pandemic.

14 May 2020

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).

14 May 2020

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.

14 May 2020

Researchers identify a group of dysregulated genes in autism

Autism has long been associated only with behavioral and environmental factors, but the role of genetics in its development is now increasingly evident. Some 100 genes have been found to play a role in autism spectrum disorder, and another thousand are being studied to the same end.

14 May 2020

Potential targets discovered for COVID-19 therapy

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people.

14 May 2020

Drug counterfeiters are using corona pandemic to make profits in Africa

Drug counterfeiters are using the corona pandemic to make profits in Africa selling completely ineffective or even harmful medicines.

14 May 2020

Modified tattoo electrodes can be used to measure brain activity

In 2015 Francesco Greco, head of the Laboratory of Applied Materials for Printed and Soft electronics (LAMPSe) at the Institute of Solid State Physics at Graz University of Technology, developed so-called "tattoo electrodes" together with Italian scientists.

14 May 2020

Cats can readily become infected with SARS-CoV-2, confirms study

In a study published today (May 13, 2020) in the New England Journal of Medicine, scientists in the U.S. and Japan report that in the laboratory, cats can readily become infected with SARS-CoV-2, the virus that causes COVID-19, and may be able to pass the virus to other cats.

14 May 2020

Laboratory News and Research

Biologic drug can help treat contact dermatitis

EKF & Tosoh Europe N.V. distribution agreement expands HbA1c POC testing reach in Middle East & Africa

Researchers investigate the troubling trend of heart injury in COVID-19 patients

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Scientists produce corals with increased heat tolerance to reduce reef bleaching

BGU researcher develops one-minute COVID-19 breath test

CSHLP Press releases new book on heart development and disease

TUM researchers develop innovative x-ray method for lung diagnostics

Army scientists apply new techniques to modify brain activity

ACMG: Technical standard on CFTR variant testing updated

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Researchers identify a group of dysregulated genes in autism

Potential targets discovered for COVID-19 therapy

Drug counterfeiters are using corona pandemic to make profits in Africa

Modified tattoo electrodes can be used to measure brain activity

Cats can readily become infected with SARS-CoV-2, confirms study

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News